<DOC>
	<DOC>NCT00668317</DOC>
	<brief_summary>The study aim is to determine the effect of 8 weeks of anti-reflux treatment (full acid suppression) on bronchial hyper-responsiveness and whether there is a symptomatic improvement.</brief_summary>
	<brief_title>Bronchial Hyper-responsiveness in Reflux Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Bronchial Hyperreactivity</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>Positive methacholine challenge test PC20 less than 4mg/ml (Can be previously documented in patients notes within last 4weeks) Written informed consent Patients with a history of chronic cough (at least 3 months duration), and associated symptoms of gastrooesophageal reflux Male and female subjects of at least 18 yrs of age Subjects able to perform satisfactory FEV1 manoeuvres Subjects able to understand the study and cooperate with the study procedures Subjects who consent to their general practitioner (GP) being informed of their study participation has had a heart attack in the last three months suffers from angina, hypertension or ischaemic heart disease has epilepsy for which he/she is taking medication FEV1&lt; 60% predicted FEV1&lt;1.6L Female subjects who are pregnant, or lactating, or who are of child bearing potential but are not using contraceptive measures Suffering from any concomitant disease which may interfere with study procedures or evaluation. A lower respiratory tract infection 4 weeks prior to entry on to study Participation in another study (use of investigational product) within 30 days preceding entry on to study. Alcohol or drug abuse Use of opiates to treat cough 1 week prior to enrollment Subjects who are taking Angiotensin Converting Enzymes (ACE) inhibitors. Subjects who have significant pathology on most recent chest XRay. Inability to understand the procedures and the implications of a challenge test Patients already taking or have taken in last 4 weeks PPI and H2 receptor antagonist (full acid suppression treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Hyper-responsiveness, reflux cough</keyword>
</DOC>